Capsugel invests in vegetarian capsules citing demand for lower moisture content and API cross-linking risk
26-Mar-2015 - Capsugel will invest $25m (€22m) to expand production of vegetarian-friendly drug and food supplement capsules.
News in brief
26-Mar-2015 - Biohaven Pharmaceutical has created a melt in the mouth anxiety drug using formulation technology licensed from Catalent.
19-Mar-2015 - 3D printers have been used to create tailor-made drug delivery tools, including bioactive radiology devices.
18-Mar-2015 - More cancer drugs are going to be delivered using nanoparticles according to Frost & Sullivan, which says research breakthroughs are going to drive adoption of such technologies.
12-Mar-2015 - New hepatitis B treatment guidelines advocate use of Gilead and BMS drugs and underline WHO concerns that needle reuse spreads the virus.
11-Mar-2015 - A type 1 diabetes vaccine will enter human trials this year according to the leader of the UK research team developing a preventative therapy for the autoimmune disorder.
10-Mar-2015 - Cancer Drug firms trying to block protein kinase Cs should rethink say researchers behind a study indicating that the enzymes suppress tumour development.
09-Mar-2015 - US desire for an alternative to the multi-shot anthrax vaccine is a boon for Glide Technologies, which had its contract extended by Pfenex this week.
Drug Delivery: Featured news
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.
Senior VP Global Vusiness Development & Marketing, Catalent